Search Results - José María Arguiñano‐Pérez
- Showing 1 - 1 results of 1
-
1
Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting by Ana Muntañola, José María Arguiñano‐Pérez, Julio Dávila, Sonia González deVillambrosia, Cecilia Carpio, Ana Jiménez‐Ubieto, Antonio Salar, the GELTAMO (Grupo español de linfomas y trasplante de médula ósea)
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book